Affluent Medical, a French clinical-phase MedTech company specializing in the international development and industrialization of innovative medical prostheses, has carried out a successful first-in-human implantation of the minimally invasive medical device Artus for the treatment of urinary incontinence as part of the European pilot study ‘Dry’.
Ultrahuman, a pioneer in wearable tech, has raised $35 million in equity and debt investment. The series B funding round saw participation from venture capital firms Blume, Steadview, Nexus, Alpha Wave and Zomato founder Deepinder Goyal. Ultrahuman will use the funds to build more manufacturing capacity and expand research in the health tracking space.
An innovative project using artificial intelligence (AI) to personalise therapies for patients with cardiovascular disease has begun following a meeting in February in Utrecht, the Netherlands.
Researchers in France have embarked on a four-year project to test the new non-invasive technique, that could help surgeons quickly and accurately assess patients for potentially life-changing complications after neck surgery. The research could have global relevance.
WillowWood Global, a leading designer, manufacturer, and distributor of prosthtic products, has acquired Xtremity. The transaction builds on WillowWood’s growing strength in custom solutions which includes central fabrication, design liners, and now fully adjustable prosthetic sockets.
WebMD Health Services has reintroduced the ‘TINYpulse’ brand, continuing its commitment to advance tools and insights that help organizations create the ultimate culture of employee engagement and well-being, while delivering a solution that clients know and trust.
As the world grapples with the far-reaching consequences of climate change, an unlikely contributor to greenhouse gas emissions emerges: the healthcare sector. A recent study [1] delves into the intricate web connecting healthcare systems and climate change, shedding light on the urgent need for transformative action to mitigate the sector’s environmental footprint.
A team of infectious diseases experts is calling for more awareness and preparedness in the medical field to deal with the impact of climate change on the spread of diseases. Their article, published in JAMA [1] raises the alarm about the emergence and spread of harmful pathogens. The authors also urge the medical community to […]
New results from the I-SPY2 phase 2 clinical trial
The vast majority of young patients given a low-dose boost of radiotherapy to the site where their breast cancer was removed in addition to whole breast radiotherapy, remained free of local recurrence after ten years, according to results of the ‘Young boost trial’ presented at the 14th European Breast Cancer Conference.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
